Scintigraphic progress of the liver in a patient with Alagille syndrome (arteriohepatic dysplasia)

Ann Nucl Med. 2003 Dec;17(8):693-7. doi: 10.1007/BF02984977.

Abstract

We encountered a 9-year-old Japanese girl with Alagille syndrome. Her scintigraphic examinations of the liver were performed at the ages of 16 months and 9 years. 99mTc-PMT, a hepatobiliary imaging agent, was distributed homogeneously in the liver at the younger age, but unevenly produced an area of focally increased uptake in the medial segment of the liver surrounded by peripheral atrophy at the older age. 99mTc-GSA, a hepatoreceptor binding agent, was highly accumulated in the area, corresponding to the focally increased uptake of 99mTc-PMT. These imaging findings suggest that the pathophysiological and morphological changes of the liver occurred in our patient during the clinical course.

Publication types

  • Case Reports

MeSH terms

  • Alagille Syndrome / diagnosis
  • Alagille Syndrome / diagnostic imaging*
  • Alagille Syndrome / metabolism
  • Child
  • Disease Progression
  • Female
  • Humans
  • Infant
  • Liver / diagnostic imaging*
  • Liver / metabolism
  • Organotechnetium Compounds* / pharmacokinetics
  • Pyrrolidines* / pharmacokinetics
  • Radionuclide Imaging
  • Radiopharmaceuticals / pharmacokinetics
  • Technetium Tc 99m Aggregated Albumin* / pharmacokinetics
  • Technetium Tc 99m Pentetate* / pharmacokinetics
  • Tetracycline* / pharmacokinetics

Substances

  • Organotechnetium Compounds
  • Pyrrolidines
  • Radiopharmaceuticals
  • Technetium Tc 99m Aggregated Albumin
  • technetium Tc 99m DTPA-galactosyl-human serum albumin
  • technetium Tc 99m pyrrolidino-methyltetracycline
  • Tetracycline
  • Technetium Tc 99m Pentetate